Resting motor threshold in navigated transcranial magnetic stimulation: relationship between inter-individual variance and distinct clinical and anatomical factors - Scorecard - MDSpire
Advertisement
Resting motor threshold in navigated transcranial magnetic stimulation: relationship between inter-individual variance and distinct clinical and anatomical factors
Clinical Scorecard: Exploring the Resting Motor Threshold in Navigated Transcranial Magnetic Stimulation: The Impact of Individual Differences and Clinical-Anatomical Factors
At a Glance
Category
Detail
Condition
Brain tumors affecting motor-eloquent brain regions
Key Mechanisms
Resting motor threshold (RMT) as a surrogate for cortical excitability measured by navigated transcranial magnetic stimulation (nTMS)
Neurosurgical preoperative planning and risk stratification
Key Highlights
RMT variability is influenced by multiple factors including age, skull-to-cortex distance, tumor characteristics, motor deficits, and medication intake.
Sodium channel–blocking antiepileptic drugs (e.g., carbamazepine) consistently increase RMT, while effects of other drugs like levetiracetam remain controversial.
Large cohort study (642 patients, 1193 RMT observations) provides comprehensive evaluation of clinical and anatomical factors affecting cortical excitability.
Guideline-Based Recommendations
Diagnosis
Use navigated TMS integrated with individual brain MRI and electromyography to map motor areas preoperatively.
Define RMT as the lowest stimulation intensity eliciting motor response in at least 5 out of 10 trials.
Measure skull-to-cortex distance (SCD) and assess tumor location, volume, and presence of motor deficits.
Management
Consider patient age, tumor characteristics, and medication profile when interpreting RMT values.
Adjust stimulation parameters based on RMT to optimize safety and efficacy during nTMS mapping.
Account for potential pharmacological effects, especially sodium channel–blocking AEDs, on cortical excitability.
Monitoring & Follow-up
Monitor RMT variability within and between patients to refine motor mapping accuracy.
Track changes in motor function and tumor progression through MRI and clinical examination.
Document medication changes that may affect RMT during preoperative assessment.
Risks
Overstimulation risks minimized by accurate RMT estimation.
Variability in RMT due to multiple factors may affect mapping reliability if unaccounted for.
Potential confounding effects of polypharmacy on cortical excitability.
Sodium channel–blocking AEDs elevate RMT; antidepressants may increase RMT; benzodiazepines generally show no direct effect; effects of levetiracetam are inconsistent.
Clinical Best Practices
Perform nTMS with concurrent MRI-based navigation and electromyography for precise motor mapping.
Use standardized methods (Rossini-Rothwell or maximum likelihood threshold-hunting) for RMT determination.
Incorporate comprehensive clinical data including age, handedness, motor deficits, tumor characteristics, and medication use in RMT interpretation.
Exclude cases with unclear tumor or edema margins from volumetric analysis to ensure data accuracy.
Apply findings from large cohort analyses to improve individualized preoperative planning and risk stratification.
